Paper8752172
A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
D'Ambrosio C and 3 others. Cancer Res, 1996. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Papers, record 8752172. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8752172
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Glioblastoma | Major topic |
| Receptor, IGF Type 1 | Major topic |
| 3T3 Cells | |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Calcium-Calmodulin-Dependent Protein Kinases | |
| Cell Division | |
| Culture Media | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Sequence Data | |
| Peptide Fragments | |
| Phosphorylation | |
| Rats | |
| Signal Transduction | |
| Solubility | |
| Tyrosine |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 53484 | NCI NIH HHS | United States | R01CA053484 | PubMed and NIH | NIH RePORTER |
| GM 33694 | NIGMS NIH HHS | United States | R01GM033694 | PubMed and NIH | NIH RePORTER |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42023590 | The IGF signaling axis in thyroid cancer: biological complexity and therapeutic challenges. | Endocr Connect | 2026 | https://conductscience.org/library/papers/42023590 | PubMed |
| 40634830 | Anthropometrics, cancer risks, and survival outcomes in adult patients with glioma - a systematic review and meta-analysis. | Acta Neurochir (Wien) | 2025 | https://conductscience.org/library/papers/40634830 | PubMed |
| 38031775 | Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma. | Curr Med Chem | 2024 | https://conductscience.org/library/papers/38031775 | PubMed |
| 36843588 | New insights on the cardiovascular effects of IGF-1. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36843588 | PubMed |
| 33962049 | Insulin-like growth factors: Ligands, binding proteins, and receptors. | Mol Metab | 2021 | https://conductscience.org/library/papers/33962049 | PubMed |
| 33163268 | Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/33163268 | PubMed |
| 32429547 | Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32429547 | PubMed |
| 32365498 | Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug. | Cells | 2020 | https://conductscience.org/library/papers/32365498 | PubMed |
| 31416218 | Therapeutic Targeting of the IGF Axis. | Cells | 2019 | https://conductscience.org/library/papers/31416218 | PubMed |
| 27462422 | Selected SNARE proteins are essential for the polarized membrane insertion of igf-1 receptor and the regulation of initial axonal outgrowth in neurons. | Cell Discov | 2015 | https://conductscience.org/library/papers/27462422 | PubMed |
| 26291053 | IGF-IR: a new prognostic biomarker for human glioblastoma. | Br J Cancer | 2015 | https://conductscience.org/library/papers/26291053 | PubMed |
| 24026884 | The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24026884 | PubMed |
| 23605083 | A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. | Breast Cancer Res Treat | 2013 | https://conductscience.org/library/papers/23605083 | PubMed |
| 21932422 | Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. | Int J Cancer | 2012 | https://conductscience.org/library/papers/21932422 | PubMed |
| 21154998 | A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers. | World J Gastroenterol | 2010 | https://conductscience.org/library/papers/21154998 | PubMed |
| 20569465 | ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20569465 | PubMed |
| 20150364 | Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma. | Neuro Oncol | 2010 | https://conductscience.org/library/papers/20150364 | PubMed |
| 16407828 | The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection. | Oncogene | 2006 | https://conductscience.org/library/papers/16407828 | PubMed |
| 15956962 | Role of insulin-like growth factor 1 receptor signalling in cancer. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15956962 | PubMed |
| 15831900 | Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts. | Gut | 2005 | https://conductscience.org/library/papers/15831900 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGF1R | 3480 | PubTator's text mining | https://conductscience.org/library/genes/3480 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8752172
GET https://conductscience.org/api/papers/v1/8752172/cited_by?page=2